ACE and Hypertension: Furthermore, a reduction in the proportion of those taking calcium channel blockers (though most patients with diagnosed (known) hypertension, 65%, continue to take one), which could again reflect preferential selection of angiotensin converting enzyme inhibitors as first line agents in those with relevant comorbidities.